Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Pollett

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Npj Viruses|April 28, 2025
Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assayDanielle W Ali, Maggie L Bartlett, Christopher D Heger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2022
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019Myron J Levin, Andrew Ustianowski, Steven Thomas, et al.
Frontiers in Public Health|May 4, 2026
Influenza-like illness in cigarette smokers and electronic-cigarette users: a secondary analysis from the PAIVED studyRachael D C Jones, Kat Schmidt, Christina Schofield, et al.
Open Forum Infectious Diseases|December 13, 2021
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019Stephanie A Richard, Nusrat J Epsi, Simon Pollett, et al.
Scientific Reports|December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
Plos Medicine|October 19, 2021
Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelinesSimon Pollett, Michael A Johansson, Nicholas G Reich, et al.
Plos Medicine|November 17, 2023
Correction: Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelinesSimon Pollett, Michael A Johansson, Nicholas G Reich, et al.
Frontiers in Immunology|September 15, 2023
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durabilityElizabeth K Graydon, Tonia L Conner, Kim Dunham, et al.
BMC Infectious Diseases|June 10, 2021
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workersBelinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, et al.
Open Forum Infectious Diseases|February 24, 2022
Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care WorkersEmilie Goguet, John H Powers, Cara H Olsen, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Npj Viruses|April 28, 2025
Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assayDanielle W Ali, Maggie L Bartlett, Christopher D Heger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2022
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019Myron J Levin, Andrew Ustianowski, Steven Thomas, et al.
Frontiers in Public Health|May 4, 2026
Influenza-like illness in cigarette smokers and electronic-cigarette users: a secondary analysis from the PAIVED studyRachael D C Jones, Kat Schmidt, Christina Schofield, et al.
Open Forum Infectious Diseases|December 13, 2021
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019Stephanie A Richard, Nusrat J Epsi, Simon Pollett, et al.
Scientific Reports|December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
Plos Medicine|October 19, 2021
Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelinesSimon Pollett, Michael A Johansson, Nicholas G Reich, et al.
Plos Medicine|November 17, 2023
Correction: Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelinesSimon Pollett, Michael A Johansson, Nicholas G Reich, et al.
Frontiers in Immunology|September 15, 2023
Natural killer cells and BNT162b2 mRNA vaccine reactogenicity and durabilityElizabeth K Graydon, Tonia L Conner, Kim Dunham, et al.
BMC Infectious Diseases|June 10, 2021
Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workersBelinda M Jackson-Thompson, Emilie Goguet, Eric D Laing, et al.
Open Forum Infectious Diseases|February 24, 2022
Prospective Assessment of Symptoms to Evaluate Asymptomatic SARS-CoV-2 Infections in a Cohort of Health Care WorkersEmilie Goguet, John H Powers, Cara H Olsen, et al.
Pageof 7